Steve Libutti

  • Steven K. Libutti, MD, FACS was named Director of Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences in January 2017. Dr. Libutti also serves as Senior Vice President of Oncology Services for RWJBarnabas Health and is a tenured Professor of Surgery at Rutgers Robert Wood Johnson Medical School. He graduated from Harvard College and received his M.D. from the College of Physicians and Surgeons of Columbia University. Following his residency in Surgery, he completed a fellowship in Surgical Oncology and Endocrine Surgery at the National Cancer Institute (NCI).

    Dr. Libutti’s research focuses on developing novel cancer therapies through an understanding of the tumor microenvironment. He is studying the interaction between tumor cells, endothelial cells and the components of the tumor microenvironment including fibroblasts and cancer stem cells. His work also focuses on a better understanding of the tumor suppressor genes MEN1 and FILIP1L. Dr. Libutti is a leader in regional cancer therapy, the management of endocrine tumors and tumor targeted gene therapy. He is a past President of the American Association of Endocrine Surgeons and also serves as the Editor-in-Chief of the Springer-Nature Journal Cancer Gene Therapy.


     

 

Leave a Reply

  • Upcoming Events

     

    World Congress on Thyroid Cancer 3.5
    Rome, Italy | 2019

    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts

     

  • WCTC3.5 Steering Committee:

     

    Rocco Bellatone, Co-Chair
    Celestino Lombardi, Co-Chair
    Gregory W. Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD